Head to head for first-timers
CoreAge Rx vs MEDVi
CoreAge Rx and MEDVi both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #31 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxMEDVi
Rank #228 for first-timers · Grade C
Mama-Match
Best for: A reader comparing brand access and named pharmacies, who is going to weigh the FDA warning letter before anything else.
Visit MEDViThe verdict for a first step
CoreAge Rx edges out MEDVi on the Mama-Match Score, 73 to 49 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
MEDVi is still a genuine option — ⛔ Carries an FDA warning letter for a misbranded compounded product (#721455, February 2026). It names its pharmacies with addresses, but publishes only the first month's price. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | MEDVi |
|---|---|---|
| Mama-Match Score | 73/100 · C | 49/100 · C |
| Overall rank | #31 | #228 |
| Semaglutide | $99/mo | From $179 the first month; no ongoing rate published |
| Tirzepatide | $149/mo | No compounded tirzepatide price on its public page |
| Coverage | Therapy-specific state restrictions; confirm eligibility | No state list on the GLP-1 page |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #31 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
MEDVi
Rank #228 · Grade C
What we like
- Names its partner pharmacies with address and phone: Triad Rx in Daphne, Alabama, and RedRock Pharmacy in St. George, Utah
- Names the company in its privacy policy: MEDVi, LLC, a Delaware corporation, in Newark
- Offers FDA-approved brand medication — Wegovy in pill and injection, and Zepbound — alongside the compounded product
The caveats
- ⛔ FDA warning letter #721455, dated February 20, 2026, to MEDVi, LLC, for false or misleading claims and a misbranded compounded product
- ⛔ Publishes only "from $179" for the first month; the ongoing rate is nowhere on the page
- "No membership or hidden fees!" sits on the same page as three brand options costing "$99 membership + medication cost"
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and MEDVi with the other providers we review for women.
Or browse the full comparison hub.